APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plant Extract Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Plant Extract Drug Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchPlant Extract Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Plant Extract Drug Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Plant Extract Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plant Extract Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Plant Extract Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Plant Extract Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Plant Extract Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Plant Extract Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Plant Extract Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Plant Extract Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Plant Extract Drug include Guangzhou Baiyunshan Pharmaceutical, Buchang Pharmaceuticals, Yunnan Baiyao, Weleda, Tsumura, Tong Ren Tang, Tasly Holding Group, Taiji and Schwabe, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Plant Extract Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Plant Extract Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Plant Extract Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Plant Extract Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plant Extract Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Plant Extract Drug revenue, projected growth trends, production technology, application and end-user industry.

Plant Extract Drug Segment by Company

Guangzhou Baiyunshan Pharmaceutical

Buchang Pharmaceuticals

Yunnan Baiyao

Weleda

Tsumura

Tong Ren Tang

Tasly Holding Group

Taiji

Schwabe

Kwangdong

Jumpcan Pharmaceutical

Huarun 999

GW Pharmaceuticals

China TCM

Bionorica Se

Plant Extract Drug Segment by Type

Prescription Drug

OTC

Plant Extract Drug Segment by Application

Tumor

Cardiovascular

Respiratory System

Other

Plant Extract Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Extract Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant Extract Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Extract Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Plant Extract Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Plant Extract Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plant Extract Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Plant Extract Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Drug Major Player Table 3. OTC Major Player Table 4. Global Plant Extract Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Tumor Major Player Table 6. Cardiovascular Major Player Table 7. Respiratory System Major Player Table 8. Other Major Player Table 9. Plant Extract Drug Industry Trends Table 10. Plant Extract Drug Industry Drivers Table 11. Plant Extract Drug Industry Opportunities and Challenges Table 12. Plant Extract Drug Industry Restraints Table 13. Global Plant Extract Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Plant Extract Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Plant Extract Drug Market Share by Region (2021-2026) Table 16. Global Plant Extract Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Plant Extract Drug Market Share by Region (2027-2032) Table 18. Global Plant Extract Drug Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Plant Extract Drug Revenue Market Share by Players (2021-2026) Table 20. Global Plant Extract Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Plant Extract Drug Key Players Headquarters & Area Served Table 22. Global Plant Extract Drug Players, Product Type & Application Table 23. Global Plant Extract Drug Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Plant Extract Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Plant Extract Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plant Extract Drug Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Plant Extract Drug Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Plant Extract Drug Revenue Market Share by Type (2021-2026) Table 30. Global Plant Extract Drug Revenue Market Share by Type (2027-2032) Table 31. Global Plant Extract Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plant Extract Drug Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Plant Extract Drug Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Plant Extract Drug Revenue Market Share by Application (2021-2026) Table 35. Global Plant Extract Drug Revenue Market Share by Application (2027-2032) Table 36. Guangzhou Baiyunshan Pharmaceutical Company Information Table 37. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 38. Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Product Portfolio Table 40. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 41. Buchang Pharmaceuticals Company Information Table 42. Buchang Pharmaceuticals Business Overview Table 43. Buchang Pharmaceuticals Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Buchang Pharmaceuticals Plant Extract Drug Product Portfolio Table 45. Buchang Pharmaceuticals Recent Development Table 46. Yunnan Baiyao Company Information Table 47. Yunnan Baiyao Business Overview Table 48. Yunnan Baiyao Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Yunnan Baiyao Plant Extract Drug Product Portfolio Table 50. Yunnan Baiyao Recent Development Table 51. Weleda Company Information Table 52. Weleda Business Overview Table 53. Weleda Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Weleda Plant Extract Drug Product Portfolio Table 55. Weleda Recent Development Table 56. Tsumura Company Information Table 57. Tsumura Business Overview Table 58. Tsumura Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Tsumura Plant Extract Drug Product Portfolio Table 60. Tsumura Recent Development Table 61. Tong Ren Tang Company Information Table 62. Tong Ren Tang Business Overview Table 63. Tong Ren Tang Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Tong Ren Tang Plant Extract Drug Product Portfolio Table 65. Tong Ren Tang Recent Development Table 66. Tasly Holding Group Company Information Table 67. Tasly Holding Group Business Overview Table 68. Tasly Holding Group Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Tasly Holding Group Plant Extract Drug Product Portfolio Table 70. Tasly Holding Group Recent Development Table 71. Taiji Company Information Table 72. Taiji Business Overview Table 73. Taiji Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Taiji Plant Extract Drug Product Portfolio Table 75. Taiji Recent Development Table 76. Schwabe Company Information Table 77. Schwabe Business Overview Table 78. Schwabe Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Schwabe Plant Extract Drug Product Portfolio Table 80. Schwabe Recent Development Table 81. Kwangdong Company Information Table 82. Kwangdong Business Overview Table 83. Kwangdong Plant Extract Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Kwangdong Plant Extract Drug Product Portfolio Table 85. Kwangdong Recent Development Table 86. Jumpcan Pharmaceutical Company Information Table 87. Jumpcan Pharmaceutical Business Overview Table 88. Jumpcan Pharmaceutical Plant Extract Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jumpcan Pharmaceutical Plant Extract Drug Product Portfolio Table 90. Jumpcan Pharmaceutical Recent Development Table 91. Huarun 999 Company Information Table 92. Huarun 999 Business Overview Table 93. Huarun 999 Plant Extract Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Huarun 999 Plant Extract Drug Product Portfolio Table 95. Huarun 999 Recent Development Table 96. GW Pharmaceuticals Company Information Table 97. GW Pharmaceuticals Business Overview Table 98. GW Pharmaceuticals Plant Extract Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GW Pharmaceuticals Plant Extract Drug Product Portfolio Table 100. GW Pharmaceuticals Recent Development Table 101. China TCM Company Information Table 102. China TCM Business Overview Table 103. China TCM Plant Extract Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. China TCM Plant Extract Drug Product Portfolio Table 105. China TCM Recent Development Table 106. Bionorica Se Company Information Table 107. Bionorica Se Business Overview Table 108. Bionorica Se Plant Extract Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bionorica Se Plant Extract Drug Product Portfolio Table 110. Bionorica Se Recent Development Table 111. North America Plant Extract Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Plant Extract Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Plant Extract Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Plant Extract Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Plant Extract Drug Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Plant Extract Drug Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Plant Extract Drug Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Plant Extract Drug Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Plant Extract Drug Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Plant Extract Drug Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Plant Extract Drug Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Plant Extract Drug Revenue by Country (US$ Million) & (2027-2032) Table 125. China Plant Extract Drug Revenue by Type (2021-2026) & (US$ Million) Table 126. China Plant Extract Drug Revenue by Type (2027-2032) & (US$ Million) Table 127. China Plant Extract Drug Revenue by Application (2021-2026) & (US$ Million) Table 128. China Plant Extract Drug Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Plant Extract Drug Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Plant Extract Drug Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Plant Extract Drug Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Plant Extract Drug Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Plant Extract Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Plant Extract Drug Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Plant Extract Drug Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Plant Extract Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Plant Extract Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Plant Extract Drug Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Plant Extract Drug Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Plant Extract Drug Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Plant Extract Drug Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Plant Extract Drug Image Figure 2. Global Plant Extract Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plant Extract Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Drug Image Figure 5. OTC Image Figure 6. Global Plant Extract Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Plant Extract Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Tumor Image Figure 9. Cardiovascular Image Figure 10. Respiratory System Image Figure 11. Other Image Figure 12. Global Plant Extract Drug Market Size (US$ Million) & (2021-2032) Figure 13. Global Plant Extract Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Plant Extract Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Plant Extract Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Plant Extract Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plant Extract Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Plant Extract Drug Revenue Market Share by Type (2021-2032) Figure 20. Global Plant Extract Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Plant Extract Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Plant Extract Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Plant Extract Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Plant Extract Drug Revenue Share by Type (2021-2032) Figure 25. North America Plant Extract Drug Revenue Share by Application (2021-2032) Figure 26. North America Plant Extract Drug Revenue Share by Country (2021-2032) Figure 27. United States Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Plant Extract Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Plant Extract Drug Revenue Share by Type (2021-2032) Figure 32. Europe Plant Extract Drug Revenue Share by Application (2021-2032) Figure 33. Europe Plant Extract Drug Revenue Share by Country (2021-2032) Figure 34. Germany Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Plant Extract Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Plant Extract Drug Revenue Share by Type (2021-2032) Figure 44. China Plant Extract Drug Revenue Share by Application (2021-2032) Figure 45. Asia Plant Extract Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Plant Extract Drug Revenue Share by Type (2021-2032) Figure 47. Asia Plant Extract Drug Revenue Share by Application (2021-2032) Figure 48. Asia Plant Extract Drug Revenue Share by Region (2021-2032) Figure 49. Japan Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Plant Extract Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Plant Extract Drug Revenue Share by Type (2021-2032) Figure 57. SAMEA Plant Extract Drug Revenue Share by Application (2021-2032) Figure 58. SAMEA Plant Extract Drug Revenue Share by Country (2021-2032) Figure 59. Brazil Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Plant Extract Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drug
  • OTC
Applications
  • Tumor
  • Cardiovascular
  • Respiratory System
  • Other
Companies covered
  • Guangzhou Baiyunshan Pharmaceutical
  • Buchang Pharmaceuticals
  • Yunnan Baiyao
  • Weleda
  • Tsumura
  • Tong Ren Tang
  • Tasly Holding Group
  • Taiji
  • Schwabe
  • Kwangdong
  • Jumpcan Pharmaceutical
  • Huarun 999
  • GW Pharmaceuticals
  • China TCM
  • Bionorica Se

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Plant Extract Drug Market by Type
  3. 1.2.1 Global Plant Extract Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Drug
  5. 1.2.3 OTC
  6. 1.3 Plant Extract Drug Market by Application
  7. 1.3.1 Global Plant Extract Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Tumor
  9. 1.3.3 Cardiovascular
  10. 1.3.4 Respiratory System
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Plant Extract Drug Market Dynamics
  1. 2.1 Plant Extract Drug Industry Trends
  2. 2.2 Plant Extract Drug Industry Drivers
  3. 2.3 Plant Extract Drug Industry Opportunities and Challenges
  4. 2.4 Plant Extract Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Plant Extract Drug Market Perspective (2021-2032)
  2. 3.2 Global Plant Extract Drug Growth Trends by Region
  3. 3.2.1 Global Plant Extract Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Plant Extract Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Plant Extract Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Plant Extract Drug Revenue by Players
  2. 4.1.1 Global Plant Extract Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Plant Extract Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Plant Extract Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Plant Extract Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Plant Extract Drug Key Players Headquarters & Area Served
  7. 4.4 Global Plant Extract Drug Players, Product Type & Application
  8. 4.5 Global Plant Extract Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Plant Extract Drug Market CR5 and HHI
  11. 4.6.3 2025 Plant Extract Drug Tier 1, Tier 2, and Tier 3
5 Plant Extract Drug Market Size by Type
  1. 5.1 Global Plant Extract Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Plant Extract Drug Revenue by Type (2021-2032)
  3. 5.3 Global Plant Extract Drug Revenue Market Share by Type (2021-2032)
6 Plant Extract Drug Market Size by Application
  1. 6.1 Global Plant Extract Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Plant Extract Drug Revenue by Application (2021-2032)
  3. 6.3 Global Plant Extract Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Guangzhou Baiyunshan Pharmaceutical
  2. 7.1.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  3. 7.1.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  4. 7.1.3 Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Guangzhou Baiyunshan Pharmaceutical Plant Extract Drug Product Portfolio
  6. 7.1.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  7. 7.2 Buchang Pharmaceuticals
  8. 7.2.1 Buchang Pharmaceuticals Company Information
  9. 7.2.2 Buchang Pharmaceuticals Business Overview
  10. 7.2.3 Buchang Pharmaceuticals Plant Extract Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Buchang Pharmaceuticals Plant Extract Drug Product Portfolio
  12. 7.2.5 Buchang Pharmaceuticals Recent Developments
  13. 7.3 Yunnan Baiyao
  14. 7.3.1 Yunnan Baiyao Company Information
  15. 7.3.2 Yunnan Baiyao Business Overview
  16. 7.3.3 Yunnan Baiyao Plant Extract Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Yunnan Baiyao Plant Extract Drug Product Portfolio
  18. 7.3.5 Yunnan Baiyao Recent Developments
  19. 7.4 Weleda
  20. 7.4.1 Weleda Company Information
  21. 7.4.2 Weleda Business Overview
  22. 7.4.3 Weleda Plant Extract Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Weleda Plant Extract Drug Product Portfolio
  24. 7.4.5 Weleda Recent Developments
  25. 7.5 Tsumura
  26. 7.5.1 Tsumura Company Information
  27. 7.5.2 Tsumura Business Overview
  28. 7.5.3 Tsumura Plant Extract Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Tsumura Plant Extract Drug Product Portfolio
  30. 7.5.5 Tsumura Recent Developments
  31. 7.6 Tong Ren Tang
  32. 7.6.1 Tong Ren Tang Company Information
  33. 7.6.2 Tong Ren Tang Business Overview
  34. 7.6.3 Tong Ren Tang Plant Extract Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Tong Ren Tang Plant Extract Drug Product Portfolio
  36. 7.6.5 Tong Ren Tang Recent Developments
  37. 7.7 Tasly Holding Group
  38. 7.7.1 Tasly Holding Group Company Information
  39. 7.7.2 Tasly Holding Group Business Overview
  40. 7.7.3 Tasly Holding Group Plant Extract Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Tasly Holding Group Plant Extract Drug Product Portfolio
  42. 7.7.5 Tasly Holding Group Recent Developments
  43. 7.8 Taiji
  44. 7.8.1 Taiji Company Information
  45. 7.8.2 Taiji Business Overview
  46. 7.8.3 Taiji Plant Extract Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Taiji Plant Extract Drug Product Portfolio
  48. 7.8.5 Taiji Recent Developments
  49. 7.9 Schwabe
  50. 7.9.1 Schwabe Company Information
  51. 7.9.2 Schwabe Business Overview
  52. 7.9.3 Schwabe Plant Extract Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Schwabe Plant Extract Drug Product Portfolio
  54. 7.9.5 Schwabe Recent Developments
  55. 7.10 Kwangdong
  56. 7.10.1 Kwangdong Company Information
  57. 7.10.2 Kwangdong Business Overview
  58. 7.10.3 Kwangdong Plant Extract Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Kwangdong Plant Extract Drug Product Portfolio
  60. 7.10.5 Kwangdong Recent Developments
  61. 7.11 Jumpcan Pharmaceutical
  62. 7.11.1 Jumpcan Pharmaceutical Company Information
  63. 7.11.2 Jumpcan Pharmaceutical Business Overview
  64. 7.11.3 Jumpcan Pharmaceutical Plant Extract Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Jumpcan Pharmaceutical Plant Extract Drug Product Portfolio
  66. 7.11.5 Jumpcan Pharmaceutical Recent Developments
  67. 7.12 Huarun 999
  68. 7.12.1 Huarun 999 Company Information
  69. 7.12.2 Huarun 999 Business Overview
  70. 7.12.3 Huarun 999 Plant Extract Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Huarun 999 Plant Extract Drug Product Portfolio
  72. 7.12.5 Huarun 999 Recent Developments
  73. 7.13 GW Pharmaceuticals
  74. 7.13.1 GW Pharmaceuticals Company Information
  75. 7.13.2 GW Pharmaceuticals Business Overview
  76. 7.13.3 GW Pharmaceuticals Plant Extract Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GW Pharmaceuticals Plant Extract Drug Product Portfolio
  78. 7.13.5 GW Pharmaceuticals Recent Developments
  79. 7.14 China TCM
  80. 7.14.1 China TCM Company Information
  81. 7.14.2 China TCM Business Overview
  82. 7.14.3 China TCM Plant Extract Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 China TCM Plant Extract Drug Product Portfolio
  84. 7.14.5 China TCM Recent Developments
  85. 7.15 Bionorica Se
  86. 7.15.1 Bionorica Se Company Information
  87. 7.15.2 Bionorica Se Business Overview
  88. 7.15.3 Bionorica Se Plant Extract Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bionorica Se Plant Extract Drug Product Portfolio
  90. 7.15.5 Bionorica Se Recent Developments
8 North America
  1. 8.1 North America Plant Extract Drug Revenue (2021-2032)
  2. 8.2 North America Plant Extract Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Plant Extract Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Plant Extract Drug Revenue by Type (2027-2032)
  5. 8.3 North America Plant Extract Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Plant Extract Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Plant Extract Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Plant Extract Drug Revenue by Application (2027-2032)
  9. 8.5 North America Plant Extract Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Plant Extract Drug Revenue by Country
  11. 8.6.1 North America Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Plant Extract Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Plant Extract Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Plant Extract Drug Revenue (2021-2032)
  2. 9.2 Europe Plant Extract Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Plant Extract Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Plant Extract Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Plant Extract Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Plant Extract Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Plant Extract Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Plant Extract Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Plant Extract Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Plant Extract Drug Revenue by Country
  11. 9.6.1 Europe Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Plant Extract Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Plant Extract Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Plant Extract Drug Revenue (2021-2032)
  2. 10.2 China Plant Extract Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Plant Extract Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Plant Extract Drug Revenue by Type (2027-2032)
  5. 10.3 China Plant Extract Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Plant Extract Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Plant Extract Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Plant Extract Drug Revenue by Application (2027-2032)
  9. 10.5 China Plant Extract Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Plant Extract Drug Revenue (2021-2032)
  2. 11.2 Asia Plant Extract Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Plant Extract Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Plant Extract Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Plant Extract Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Plant Extract Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Plant Extract Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Plant Extract Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Plant Extract Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Plant Extract Drug Revenue by Country
  11. 11.6.1 Asia Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Plant Extract Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Plant Extract Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Plant Extract Drug Revenue (2021-2032)
  2. 12.2 SAMEA Plant Extract Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Plant Extract Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Plant Extract Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Plant Extract Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Plant Extract Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Plant Extract Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Plant Extract Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Plant Extract Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Plant Extract Drug Revenue by Country
  11. 12.6.1 SAMEA Plant Extract Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Plant Extract Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Plant Extract Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst